USD 6.21
(-5.48%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 46.78 Million | 57.15 Million | 48.35 Million | 31.76 Million | 32.45 Million | 39.21 Million |
Net Income | -38.86 Million | 29.78 Million | 60.46 Million | 21.84 Million | 36.99 Million | 38.59 Million |
Depreciation & Amortization | 1.3 Million | -1.02 Million | 9.89 Million | 892 Thousand | 667 Thousand | 5.72 Million |
Deferred income taxes | -8.04 Million | - | -9.89 Million | 23.3 Million | -667 Thousand | -5.72 Million |
Stock-based compensation | 3.99 Million | 2.87 Million | 1.94 Million | 1.33 Million | 1.88 Million | 1.1 Million |
Change in working capital | -19.51 Million | -15.08 Million | -16.34 Million | -15.5 Million | -6.64 Million | 749 Thousand |
Other non-cash items | 107.91 Million | 40.61 Million | 2.29 Million | -104 Thousand | 223 Thousand | -1.22 Million |
Investing Cash Flow | 127.46 Million | 193.17 Million | -699.68 Million | -81.86 Million | -174.42 Million | 157.92 Million |
Investments in PPE | - | - | -144 Thousand | -274 Thousand | -1.68 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -27.87 Million | -150 Thousand | -274 Thousand | -1.68 Million | - |
Sales/Maturities of investments | - | 2.08 Million | - | - | - | - |
Other Investing Activities | 127.46 Million | 218.96 Million | -699.39 Million | -81.31 Million | -171.05 Million | 157.92 Million |
Financing Cash Flow | -205.06 Million | -159.66 Million | 627.17 Million | 119.24 Million | 136.14 Million | -214.39 Million |
Debt repayment | -120.46 Million | -561.68 Million | -1.12 Billion | -94.14 Million | -843.18 Million | -822.22 Million |
Dividends payments | -75.95 Million | -71.8 Million | -58.42 Million | -42.76 Million | -37.48 Million | -32.08 Million |
Common Stock Repurchased | -4.6 Million | - | 1.61 Billion | - | - | - |
Common Stock Issuance | - | 106.26 Million | 204.77 Million | 72.93 Million | - | - |
Other Financing Activities | -4.04 Million | 367.56 Million | -13.39 Million | 67.86 Million | 1.01 Billion | 639.91 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | -1.44 Million | 1.42 Million | 1 Million | 389 Thousand | -402 Thousand | 535 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -18.06 Million | -16.51 Million | -17.35 Million | -15.89 Million | -6.24 Million | 214 Thousand |
Cash at beginning of period | 141.27 Million | 50.61 Million | 74.77 Million | 5.63 Million | 11.46 Million | 28.72 Million |
Cash at end of period | 110.45 Million | 141.27 Million | 50.61 Million | 74.77 Million | 5.63 Million | 11.46 Million |
Capital Expenditure | - | - | -144 Thousand | -274 Thousand | -1.68 Million | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -30.81 Million | 90.66 Million | -24.16 Million | 69.14 Million | -5.83 Million | -17.25 Million |
Free Cash Flow | 46.78 Million | 57.15 Million | 48.2 Million | 31.48 Million | 30.76 Million | 39.21 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6.12 Million | -12.32 Million | -39.41 Million | -38.86 Million | 9.18 Million | -2.19 Million |
Depreciation & Amortization | 999 Thousand | 1.01 Million | 1.03 Million | 1.3 Million | 265 Thousand | - |
Deferred income taxes | - | - | -3.07 Million | -8.04 Million | 6.49 Million | - |
Stock-based compensation | 1.15 Million | 1.28 Million | 1.04 Million | 3.99 Million | 985 Thousand | 1 Million |
Change in working capital | -1.18 Million | -695 Thousand | -471 Thousand | -19.51 Million | -4.33 Million | -6.06 Million |
Other non-cash items | 16.72 Million | 25.26 Million | 50.96 Million | 107.91 Million | 950 Thousand | 19.15 Million |
Investing Cash Flow | -295 Thousand | 134.01 Million | 85.84 Million | 127.46 Million | -47.68 Million | 19.24 Million |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 427 Thousand | 232 Thousand | 85.84 Million | 127.46 Million | -47.68 Million | 19.24 Million |
Financing Cash Flow | -37.24 Million | -156.33 Million | -46.49 Million | -205.06 Million | -47.44 Million | -42.3 Million |
Debt repayment | -23.44 Million | -138.11 Million | -26.72 Million | -120.46 Million | -26.9 Million | -17.65 Million |
Dividends payments | -13.79 Million | -18.22 Million | -18.08 Million | -75.95 Million | -19.18 Million | -19.34 Million |
Common Stock Repurchased | - | - | - | -4.6 Million | - | -4.6 Million |
Common Stock Issuance | - | - | -4.6 Million | - | - | - |
Other Financing Activities | -2.25 Million | -370 Thousand | -1.69 Million | -4.04 Million | -1.35 Million | -704 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | 245 Thousand | 146 Thousand | 43 Thousand | -1.44 Million | -714 Thousand | 907 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -1.42 Million | -841 Thousand | -514 Thousand | -18.06 Million | -3.62 Million | -6.97 Million |
Cash at beginning of period | 99.51 Million | 110.45 Million | 61.01 Million | 141.27 Million | 142.6 Million | 153.76 Million |
Cash at end of period | 70.64 Million | 99.51 Million | 110.45 Million | 110.45 Million | 61.01 Million | 142.6 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | -81.85 Million | - | 81.85 Million | - |
Net cash flow / Change in cash | -28.86 Million | -10.94 Million | 49.44 Million | -30.81 Million | -81.58 Million | -11.16 Million |
Free Cash Flow | 8.66 Million | 11.37 Million | 10.08 Million | 46.78 Million | 13.54 Million | 11.9 Million |
BIO
KREF
CIM-PB
LCTX
ALSE
OGC